These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1100591)

  • 1. Resistance to trimethoprim in Klebsiellae isolated before its introduction.
    Hamilton-Miller JM; Grey D
    J Antimicrob Chemother; 1975 Jun; 1(2):213-8. PubMed ID: 1100591
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 5. The resistance of 150 Klebsiella and E. coli strains isolated from patients suffering from bacteriaemia.
    Brandberg A; Lindblom GB; Franzén C
    Scand J Infect Dis Suppl; 1976; (8):103-5. PubMed ID: 779005
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-resistant coliforms.
    Lacey RW; Bruten DM; Gillespie WA; Lewis EL
    Lancet; 1972 Feb; 1(7747):409-10. PubMed ID: 4110643
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
    Bushby SR
    J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
    [No Abstract]   [Full Text] [Related]  

  • 9. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year].
    Yala F
    Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cotrimoxazole resistance of Escherichia coli].
    Digranes A; Madsen ST
    Tidsskr Nor Laegeforen; 1979 Feb; 99(3):168, 156. PubMed ID: 369032
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.
    Acar JF; Goldstein F; Chabbert YA
    J Infect Dis; 1973 Nov; 128():Suppl:470-7 p. PubMed ID: 4585953
    [No Abstract]   [Full Text] [Related]  

  • 15. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 16. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibacterial effect of sulfanilamide combination drugs].
    Metz H; Preac-Mursic V
    Med Klin; 1972 Dec; 67(49):1626-31. PubMed ID: 4566636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.